In the latest trading session,, 0.48 million Akoya Biosciences Inc (NASDAQ:AKYA) shares changed hands as the company’s beta touched 1.26. With the company’s most recent per share price at $2.21 changing hands around $0.24 or 12.47% at last look, the market valuation stands at $109.15M. AKYA’s current price is a discount, trading about -298.19% off its 52-week high of $8.80. The share price had its 52-week low at $1.88, which suggests the last value was 14.93% up since then. When we look at Akoya Biosciences Inc’s average trading volume, we note the 3-month average coming to 278.25K.
Akoya Biosciences Inc (NASDAQ:AKYA) trade information
Instantly AKYA is in green as seen in intraday trades today. With action -21.35%, the performance over the past five days has been red. The jump to weekly highs of 2.8000 added 12.47% to the stock’s daily price. The company’s shares are showing year-to-date downside of -54.71%, with the 5-day performance at -21.35% in the red. However, in the 30-day time frame, Akoya Biosciences Inc (NASDAQ:AKYA) is -41.84% down.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Akoya Biosciences Inc (AKYA) estimates and forecasts
Data shows that the Akoya Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -50.67% over the past 6 months, a 36.36% in annual growth rate that is considerably higher than the industry average of 15.30%. Year-over-year growth is forecast to reach 7.20% up from the last financial year.
Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 23.67M. 7 analysts are of the opinion that Akoya Biosciences Inc’s revenue for the current quarter will be 28.74M. The company’s revenue for the corresponding quarters a year ago was 22.44M and 25.12M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 5.50%. The estimates for the next quarter sales put growth at 14.40%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -37.60%. The 2024 estimates are for Akoya Biosciences Inc earnings to increase by 28.71%.
AKYA Dividends
Akoya Biosciences Inc is expected to release its next quarterly earnings report in June.
